Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2017 | $4,582 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2012 | $4,408 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | Maryland | state | 2005 | $4,398 | | tax credit/rebate |
CNS Therapeutics, Inc. | Mallinckrodt | North Carolina | state | 2017 | $4,395 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2020 | $4,380 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $4,377 | | property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2004 | $4,364 | | tax credit/rebate; property tax abatement |
ILLUMIGEN BIOSCIENCES INC | Merck | Washington | state | 2005 | $4,341 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2013 | $4,304 | | tax credit/rebate |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2005 | $4,276 | | tax credit/rebate; property tax abatement |
VENTANA USA | Roche | Pennsylvania | state | 2020 | $4,200 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Maryland | state | 2017 | $4,134 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2016 | $4,018 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2013 | $4,011 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2010 | $4,000 | | property tax abatement |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2015 | $3,976 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2014 | $3,933 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2016 | $3,912 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Maryland | state | 2020 | $3,909 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2012 | $3,891 | | tax credit/rebate |
Alpharma Specialty Pharma, Inc. | Pfizer | North Carolina | state | 2012 | $3,885 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2017 | $3,885 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2011 | $3,872 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2020 | $3,835 | | tax credit/rebate |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2014 | $3,832 | | property tax abatement |
King Pharmaceuticals Research and Development, Inc. | Pfizer | North Carolina | state | 2016 | $3,809 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2011 | $3,743 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2013 | $3,605 | | tax credit/rebate |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2016 | $3,600 | | property tax abatement |
Amgen USA, Inc. | Amgen | Pennsylvania | state | 2014 | $3,556 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | North Carolina | state | 2015 | $3,513 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | North Carolina | state | 2021 | $3,478 | | tax credit/rebate |
Forest Laboratories, Inc. | AbbVie | New York | local | 2013 | $3,462 | | tax credit/rebate; property tax abatement |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2015 | $3,448 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2015 | $3,442 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2004 | $3,426 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2008 | $3,313 | | property tax abatement |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2015 | $3,313 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2012 | $3,278 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2009 | $3,278 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2010 | $3,278 | | property tax abatement |
PFIZER INC | Pfizer | Tennessee | local | 2011 | $3,278 | | property tax abatement |
Amgen USA, Inc. | Amgen | North Carolina | state | 2012 | $3,274 | | tax credit/rebate |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2017 | $3,242 | | property tax abatement |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2016 | $3,214 | | tax credit/rebate |
Novo Nordisk Inc | Novo Holdings A/S | Maryland | state | 2021 | $3,194 | | tax credit/rebate |
Regeneron Renovation | Regeneron Pharmaceuticals | New York | local | 2017 | $3,178 | | tax credit/rebate |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2015 | $3,126 | | property tax abatement |
Mallinckrodt ARD, Inc. | Mallinckrodt | North Carolina | state | 2017 | $3,047 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2010 | $3,040 | | property tax abatement |
PFIZER, INC | Pfizer | Tennessee | local | 2014 | $3,011 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2011 | $2,980 | | property tax abatement |
Sprout Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2016 | $2,940 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE | Johnson & Johnson | Tennessee | local | 2007 | $2,930 | | property tax abatement |
IDEXX VETERINARY SERVICES INC | IDEXX Laboratories | Maine | state | 2009 | $2,758 | | property tax abatement |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2004 | $2,732 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2013 | $2,677 | | tax credit/rebate; property tax abatement |
PFIZER, INC | Pfizer | Tennessee | local | 2011 | $2,666 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2013 | $2,613 | | property tax abatement |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2011 | $2,611 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $2,584 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2014 | $2,578 | | property tax abatement |
Amgen USA, Inc. | Amgen | North Carolina | state | 2011 | $2,572 | | tax credit/rebate |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2018 | $2,511 | | property tax abatement |
IDEXX PHARMACEUTICALS INC | IDEXX Laboratories | Maine | state | 2019 | $2,511 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2012 | $2,364 | | property tax abatement |
Lung Biotechnology, Inc. | United Therapeutics | North Carolina | state | 2016 | $2,270 | | tax credit/rebate |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2013 | $2,237 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2013 | $2,120 | | tax credit/rebate |
CNS Therapeutics, Inc. | Mallinckrodt | North Carolina | state | 2015 | $2,115 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2011 | $1,996 | | property tax abatement |
Pharmacia Corporation | Pfizer | Maryland | state | 2004 | $1,884 | | tax credit/rebate |
Chimerix, Inc. | Chimerix | North Carolina | state | 2013 | $1,816 | | tax credit/rebate |
Idexx Pharmaceuticals LLC | IDEXX Laboratories | Maine | state | 2021 | $1,773 | | property tax abatement |
Mallinckrodt, Inc. (DE) | Mallinckrodt | North Carolina | state | 2010 | $1,742 | | tax credit/rebate |
JOHNSON & JOHNSON | Johnson & Johnson | Tennessee | local | 2008 | $1,663 | | property tax abatement |
Amgen USA, Inc. | Amgen | North Carolina | state | 2014 | $1,644 | | tax credit/rebate |
Albany Molecular Research | Curia Inc. | New York | local | 2012 | $1,624 | | tax credit/rebate; property tax abatement |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2012 | $1,623 | | property tax abatement |
Gilead Palo Alto, Inc. | Gilead Sciences | North Carolina | state | 2010 | $1,517 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2013 | $1,515 | | property tax abatement |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2012 | $1,480 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2014 | $1,480 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $1,441 | | tax credit/rebate |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $1,440 | | training reimbursement |
Valmed Parmaceuticals, Inc. | AbbVie | New York | local | 2005 | $1,375 | | tax credit/rebate; property tax abatement |
ICOS CORPORATION | Eli Lilly | Washington | state | 2007 | $1,375 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2015 | $1,362 | | tax credit/rebate |
PFIZER INC | Pfizer | Tennessee | local | 2012 | $1,333 | | property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2006 | $1,312 | | tax credit/rebate; property tax abatement |
Astellas Pharma US, Inc. | Astellas Pharma | Maryland | state | 2007 | $1,236 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2005 | $1,205 | | tax credit/rebate |
Valmed Pharmaceuticals, Inc. | AbbVie | New York | local | 2019 | $1,159 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Pennsylvania | state | 2018 | $1,157 | | tax credit/rebate |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2014 | $1,144 | | property tax abatement |
BioDelivery Sciences International, Inc. | BioDelivery Sciences International | North Carolina | state | 2018 | $1,141 | | tax credit/rebate |
Wyeth Pharmaceuticals, Inc. | Pfizer | North Carolina | state | 2013 | $1,058 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2015 | $1,019 | | tax credit/rebate |
Intervet Inc. | Merck | Kansas | state | 2021 | $1,000 | | training reimbursement |
Pfizer, Inc. | Pfizer | Missouri | local | 2017 | | $220,000,000 | loan or bond financing |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |